| Analysis at 6/18/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 8.16% | 53.91% | 48.70% | 60.34% |
| Analysis at 6/18/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 17.18% | 17.86% | 16.85% |
| Negative volatility | 4.40% | 10.21% | 9.99% |
| Sharpe | 2.49 | 0.66 | 0.58 |
| Sortino | 9.71 | 1.16 | 0.98 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology C $ | 5.46% | 4.61% | 3.44% | 9.08% | 22.51% | 8.16% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | -2.05% | |